Abstract
We synthesized linear and cyclic pentapeptides corresponding to the sequence 369-373 of human immunoglobulin G heavy chain—VKGFY (referred to as pentarphin and cyclopentarphin, respectively). The effect of pentarphin and cyclopentarphin on phagocytosis of Salmonella typhimurium virulent 415 strain bacteria by mouse peritoneal macrophages in vitro was studied. Control experiments showed that macrophages actively captured these bacteria, but did not digest them: the captured microbes were viable and continued to proliferate inside the phagocytes; within 12 h all macrophage monolayer was destroyed (incomplete phagocytosis). If 1 nM pentarphin or cyclopentarphin was added to the cultivation medium, macrophage bactericidal activity was significantly increased and they digested all captured microorganisms within 6 h (complete phagocytosis). To study the receptor binding properties of pentarphin and cyclopentarphin we prepared 125I-labeled pentarphin (179 Ci/mmol specific activity). The binding of 125I-labeled pentarphin to mouse peritoneal macrophages was highaffinity (K d = 3.6 ± 0.3 nM) and saturable. Studies on binding specificity revealed that this binding was insensitive to naloxone and [Met5]enkephalin, but completely inhibited by unlabeled cyclopentarphin (K i = 2.6 ± 0.3 nM), immunorphin (K i = 3.2 ± 0.3 nM), and β-endorphin (K i = 2.8 ± 0.2 nM). Thus, the effects of pentarphin and cyclopentarphin on macrophages are mediated by naloxone-insensitive receptors common for pentarphin, cyclopentarphin, immunorphin, and β-endorphin.
Similar content being viewed by others
REFERENCES
Najiar, V. A., and Nashioka, K. (1970) Nature, 228, 672-673.
Herman, Z. S., Stachura, Z., Opielka, L., Siemion, I. Z., and Nawrocha, E. (1981) Experientia, 37, 76-77.
Herman, Z. S., Stachura, Z., Kraemifski, T., Plech, A., Siemion, I. Z., and Nawrocha, E. (1983) Ann. N. Y. Acad. Sci., 419, 156-163.
Val'dman, A. V., Bondarenko, N. A., Kamysheva, V. A., Kozlovskaia, M. M., and Kalikhevich, V. N. (1982) Byul. Eksp. Biol. Med., 93, 57-60.
Julliard, J. H., Shibasaki, T., Ling, N., and Guilemin, R. (1980) Science, 208, 183-185.
Houck, J. C., Kimbull, C., Chang, C., Pedigo, N. W., and Yamamura, H. J. (1980) Science, 207, 78-80.
Zav'yalov, V. P., Zaitseva, O. R., Navolotskaya, E. V., Abramov, V. M., Volodina, E. Yu., and Mitin, Y. V. (1996) Immunol. Lett., 49, 21-26.
Navolotskaya, E. V., Malkova, N. V., Lepikhova, T. N., Krasnova, S. B., Zargarova, T. A., Zav'yalov, V. P., and Lipkin, V. M. (2001) Bioorg. Chem. (Moscow), 27, 359-363.
Navolotskaya, E. V., Zargarova, T. A., Malkova, N. V., Lepikhova, T. N., Zav'yalov, V. P., and Lipkin, V. M. (2001) Peptides, 22, 2009-2013.
Navolotskaya, E. V., Malkova, N. V., Zargarova, T. A., Krasnova, S. B., and Lipkin, V. M. (2002) Biochemistry (Moscow), 67, 357-363.
Navolotskaya, E. V., Zargarova, T. A., Malkova, N. V., Krasnova, S. B., Zav'yalov, V. P., and Lipkin, V. M. (2002) Biochem. Biophys. Res. Commun., 292, 799-804.
Gershkovitch, A. A., and Kibirev, V. K. (1992) Chemical Peptide Synthesis [in Russian], Naukova Dumka, Kiev, pp. 95-283.
Schnolzer, M., Alewood, P., Jones, A., Alewood, D., and Kent, S. B. H. (1992) Int. J. Peptide Protein Res., 40, 180-193.
Nakagawa, S. H., and Kaiser, E. T. (1983) J. Org. Chem., 48, 678-685.
Uchitel, I. Ya. (1978) Macrophages in the Immunity [in Russian], Meditsina, Moscow, pp. 168-180.
Navolotskaya, E. V. (1994) Structure_functional studies of human α2-interferon, interleukin 2 and immunoglobulin G using synthetic peptides: Doctoral dissertation [in Russian], Institute of Immunology, Moscow.
Salacinski, P. R. P., Lean, C. M., Sykes, J. E. C., Climent-Jones, V. V., and Lowry, P. J. (1981) Analyt. Biochem., 117, 136-146.
Chang, K.-J., Jacobs, S., and Cuatrecasas, P. (1975) Biochim. Biophys. Acta, 406, 294-303.
Chang, Y. C., and Prusoff, W. H. (1973) Biochem. Pharmacol., 22, 3099-3108.
Prishchepov, E. D., Erin, A. N., Perelygin, V. V., and Vorob'ev, A. A. (1984) J. Microbiol. Epidemiol. Immunobiol. (Moscow), 6, 3-9.
Bromberg, Y., and Pick, E. (1981) Cell. Immunol., 61, 90-103.
Lew, P. D. (1989) Eur. J. Clin. Invest., 19, 338-346.
Stendahl, O., Krause, K. H., Kricher, J., Jerstrom, P., Theler, J. M., Clark, R. A., Carpentier, J. L., and Leu, D. P. (1994) Science, 265, 1439-1441.
Theler, J. M., Lew, D. P., Jaconi, M. E., Krause, K. H., Wollheim, C. B., and Schlegel, W. (1995) Blood, 85, 2194-2201.
Clapham, D. (1995) Cell, 80, 259-268.
Helberg, C., Molony, L., Zheng, L., and Andersson, T. (1996) Biochem. J., 317, 403-409.
Berridge, M. (1997) J. Physiol., 499, 291-306.
Malik, Z. A., Denning, G. M., and Kusner, D. J. (2000) J. Exp. Med., 191(2), 287-302.
Gemza, D., Seitz, M., Kramer, W., Grimm, W., Till, G., and Resch, K. (1979) Exp. Cell. Res., 118, 55-62.
Pick, E., and Keisari, Y. (1981) Cell. Immunol., 59, 301-308.
Weidemann, M. J., Peskar, B. A., Wrogemann, K., Rietschel, E. T., Staudinder, H., and Fisher, H. (1978) FEBS Lett., 89, 136-140.
Leu, P. D., and Stassel, T. P. (1981) J. Clin. Invest., 67, 1-9.
Wong, P. Y. K., and Cheung, W. Y. (1979) Biochem. Biophys. Res. Commun., 90, 473-480.
Welsh, M. J., Dedman, J. R., Brinkley, B. R., and Means, A. R. (1979) J. Cell. Biol., 81, 624-634.
Navolotskaya, E. V., Zargarova, T. A., Malkova, N. V., Krasnova, S. B., Zav'yalov, V. P., and Lipkin, V. M. (2002) Peptides, 23, 1115-1119.
Li, C. H. (1982) Cell, 31, 504-505.
Korpela, T., Navolotskaya, E. V., Zargarova, T. A., and Zav'yalov, V. P. (2002) Patent F120020121AO. Finland. Pub. Date 23.01.2002.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Navolotskaya, E.V., Kolobov, A.A., Kampe-Nemm, E.A. et al. Synthetic Peptide VKGFY and Its Cyclic Analog Stimulate Macrophage Bactericidal Activity through Non-Opioid β-Endorphin Receptors. Biochemistry (Moscow) 68, 34–41 (2003). https://doi.org/10.1023/A:1022137216874
Issue Date:
DOI: https://doi.org/10.1023/A:1022137216874